← Back to Clinical Trials
Recruiting NCT06913894

NCT06913894 Supervised vs. Home-Based vs. No Therapy for Uncomplicated Distal Radius Fracture in Younger Adults

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06913894
Status Recruiting
Phase —
Sponsor Al Hayah University In Cairo
Condition Distal Radius Fractures
Study Type INTERVENTIONAL
Enrollment 96 participants
Start Date 2025-04-21
Primary Completion 2026-04-21

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Supervised Therapy for DRF RehabilitationHome-Based Rehabilitation Program for DRFMinimal Educational Intervention for DRF

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 96 participants in total. It began in 2025-04-21 with a primary completion date of 2026-04-21.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This three-arm, parallel-group RCT will compare the effectiveness of three rehabilitation strategies following conservative treatment of an uncomplicated distal radius fracture in adults under 50 years old. The study will compare: Supervised Therapy: Outpatient physical therapy sessions plus a daily home exercise program Home-Based Program: A structured, detailed home exercise program with weekly telephone follow-up No Therapy (minimal intervention): Standard minimal instruction via an educational brochure The primary outcome is the Patient-Rated Wrist Evaluation (PRWE) measured at 6 weeks and 6 months.

Eligibility Criteria

Inclusion Criteria: Adults aged 18-50 years. Diagnosed with an extra-articular, stable distal radius fracture treated nonoperatively with a short-arm cast for approximately 4-6 weeks. The fracture is uncomplicated (no significant soft-tissue injury, no evidence of CRPS, and no other major complications). Willing to provide written informed consent and comply with follow-up assessments. Exclusion Criteria: Intra-articular or unstable fracture patterns. Surgical intervention planned or performed for the distal radius fracture. Presence of significant comorbidities (e.g., chronic inflammatory arthritis or severe neurological impairment affecting the injured limb). Fracture complications such as CRPS or major soft-tissue injury. Inability to comply with study procedures or follow-up assessments. Pregnant or breastfeeding individuals.

Contact & Investigator

Central Contact

Ibrahim Zoheiry, Ph.D

✉ ibrahim.alzoheiry@hotmail.com

📞 01277774949

Frequently Asked Questions

Who can join the NCT06913894 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Distal Radius Fractures. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06913894 currently recruiting?

Yes, NCT06913894 is actively recruiting participants. Contact the research team at ibrahim.alzoheiry@hotmail.com for enrollment information.

Where is the NCT06913894 trial being conducted?

This trial is being conducted at Cairo, Egypt.

Who is sponsoring the NCT06913894 clinical trial?

NCT06913894 is sponsored by Al Hayah University In Cairo. The trial plans to enroll 96 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology